Camrese Lo and Pilocarpine Eye Drops
Determining the interaction of Camrese Lo and Pilocarpine Eye Drops and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: ethinyl estradiol / levonorgestrel
Brand name: Amethia, Amethia Lo, Camrese, Camrese Lo, Daysee, Introvale, Jolessa, LoSeasonique, Quartette, Quasense, Seasonale, Seasonique, Afirmelle, Altavera, Amethyst, Ashlyna, Aubra, Aubra EQ, Aviane, Ayuna, Balcoltra, Chateal, Chateal EQ, Delyla, Enpresse-28, FaLessa, Falmina, Fayosim, Kurvelo, Larissia, Lessina, Levonest, Levora 015/30, Lillow, Lutera, Marlissa, Myzilra, Orsythia, Portia-28, Rivelsa, Setlakin, Simpesse, Sronyx, Trivora, Vienva, Alesse, Enpresse, Levlen, Levora, Lybrel, Nordette, Portia, Tri-Levlen, Triphasil-21, Triphasil-28, Trivora-28, Preven EC, Triphasil
Synonyms: Camrese Lo (extended-cycle)
Generic Name: pilocarpine ophthalmic
Brand name: Pilocar, Pilopine-HS, Pilostat, Isopto Carpine, Adsorbocarpine, Pilagan with C Cap, Ocu-Carpine, Ocusert, Piloptic-1/2, Piloptic-1, Akarpine, Piloptic-2, Piloptic-3, Piloptic-4, Piloptic-6
Synonyms: Pilocarpine ophthalmic, Pilocarpine (Ophthalmic)
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Camrese Lo-Pilocarpine Hydrochloride
- Camrese Lo-Pilocarpine ophthalmic
- Camrese Lo-Pilocarpine Tablets
- Camrese Lo-Pilopine-HS
- Camrese Lo-Pilostat
- Camrese Lo-Pima
- Pilocarpine Eye Drops-Camrese Lo extended-cycle
- Pilocarpine Eye Drops-Canagliflozin
- Pilocarpine Eye Drops-Canagliflozin and metformin
- Pilocarpine Eye Drops-Canagliflozin and Metformin Extended-Release Tablets
- Pilocarpine Eye Drops-Canagliflozin and Metformin Tablets
- Pilocarpine Eye Drops-Canakinumab